Letters to the Editor
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic’s third wave
M. Tasso1, E. Mostacciuolo2, V. Ugoccioni3, A. Del Puente4, R. Peluso5, R. Scarpa6, L. Costa7, F. Caso8
- Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
- Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
- Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
- Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
- Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
- Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. rscarpa@unina.it
- Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
- Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
CER14905
2022 Vol.40, N°5
PI 1061
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 35084304 [PubMed]
Received: 16/06/2021
Accepted : 19/07/2021
In Press: 27/01/2022
Published: 13/05/2022
